NeuroBasic PharmaPhenomics

NeuroBasic PharmaPhenomics

NeuroBasic PharmaPhenomics is a research consortium with several academic and commercial partners that builds on the successes of Neuro-Bsik. It aims to develop new drug discovery strategies in both neurology and psychiatry. They use a novel approach; improving early stage drug development with so called pharma-phenomics, well-characterized genetic animal models and response classification systems. The project is funded by the Dutch science ministry and VU Amsterdam.

The final meeting of this consortium was held in January 2016. Kennislink published an overview of the research projects on their website: The next generation of neuropharmaceutical drugs

Subsidy: approximately € 13.500.000,-

i3B partners: Noldus IT, Wageningen UR,

Websiteclick here

Status:  finalised January, 2016